http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2545759-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10d432da23a2d042b6822de00c28f98d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a960405d0756fa2acb319fb36a28082b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3525c4972ad18e0436f1f6d5f42b22d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b3355ee0e879ff9bbd0dcec79f4c0dc
publicationDate 2015-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2545759-T3
titleOfInvention Human anti-TSHR antibodies
abstract An isolated antibody molecule that binds to TSHR to stimulate TSHR, the antibody molecule comprising an antibody VL domain comprising SEQ ID NO: 24 for CDR I, SEQ ID NO: 25 for CDR II and SEQ ID NO: 26 for CDR III and an antibody VH domain comprising SEQ ID NO: 6 for CDR I, SEQ ID NO: 7 for CDR II and SEQ ID NO: 8 for CDR III.
priorityDate 2008-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553823
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05700
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21948
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81800
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00634
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19147
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05205
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83456
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID289699
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO60109
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID289699
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3054

Total number of triples: 44.